-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Lc+THXuinOlCOu7zIgjfQuLmZGWgaYvQG0hBnIQkIq5UfqvpAbgNoYv4UhjGyQ6k s9dpPDFkC/JbUiql4EEGJg== 0001104659-07-058452.txt : 20070802 0001104659-07-058452.hdr.sgml : 20070802 20070802185836 ACCESSION NUMBER: 0001104659-07-058452 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070801 FILED AS OF DATE: 20070802 DATE AS OF CHANGE: 20070802 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: D-322 AP6D CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 8479376100 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REYNOLDS W ANN CENTRAL INDEX KEY: 0001018652 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 071021819 BUSINESS ADDRESS: BUSINESS PHONE: 5025803778 MAIL ADDRESS: STREET 1: 500 WEST MAIN STREET CITY: LOUISVILLE STATE: KY ZIP: 40202 4 1 a4.xml 4 X0202 4 2007-08-01 0 0000001800 ABBOTT LABORATORIES ABT 0001018652 REYNOLDS W ANN 130 WEST 67TH STREET, APT. 21A NEW YORK NY 10023 1 0 0 0 Common shares without par value 2007-08-01 4 M 0 1436 30.2428 A 40168 D Common shares without par value 2007-08-01 4 M 0 2881 30.1958 A 43049 D Common shares without par value 2007-08-01 4 F 0 2572 50.69 D 40477 D Common shares without par value 1716 I By husband's simplified employee plan Common shares without par value 732 I By husband's IRA Option (right to buy) 30.2428 2007-08-01 4 M 0 1436 0 D 1997-09-30 2007-09-29 Common shares 1436 0 D Option (right to buy) 30.1958 2007-08-01 4 M 0 2881 0 D 1997-10-10 2007-10-09 Common shares 2881 0 D Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions were exempt from Section 16 under Rule 16a-11. The reporting person disclaims beneficial ownership of all securities held by her husband. Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Deborah K. Koenen, by power of attorney for W. Ann Reynolds 2007-08-02 -----END PRIVACY-ENHANCED MESSAGE-----